Bcl‐2 overexpression is a hallmark of HCC resistance to chemotherapy, as it inhibits mitochondrial outer membrane permeabilization (MOMP), preventing cytochrome c release and apoptotic cascade activation [64]. The gene discussed is CYCS; the disease is hepatocellular carcinoma.